Peter Novak
Harvard · Brigham and Women's Hospital · Former Associate Professor
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter Novak as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:19 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06305780 · RECOVER-AUTONOMIC Platform ProtocolKanecia Obie Zimmerman · completed · Long COVID, Long Covid19, Long Covid-19 · study chair
- Ph2NCT06305806 · RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)Kanecia Obie Zimmerman · completed · Long COVID, Long Covid19, Long Covid-19 · study chair
- Ph2NCT06305793 · RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)Kanecia Obie Zimmerman · completed · Long COVID, Long Coronavirus Disease 2019 (Covid19), Long Covid-19 · study chair
- Ph2NCT02415556 · Memory Aid by Intranasal Insulin in Diabetes (MemAID)Beth Israel Deaconess Medical Center · completed · Type 2 Diabetes Mellitus · principal investigator
- Ph2NCT02064166 · Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.Peter Novak · completed · Parkinson Disease, Multiple System Atrophy · principal investigator
- Ph2NCT00750867 · Treatment of Multiple System Atrophy Using Intravenous ImmunoglobulinsUniversity of Massachusetts, Worcester · completed · Multiple System Atrophy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID)R01DK103902 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Vera Novak · fiscal years 2015 to 2019Named on NCT02415556
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:19 UTC. The ranking covers the 200 most relevant of 57 PubMed records, and a shared surname and initials can bring in a namesake. All 57 on PubMed
- Approaches to catheter ablation for persistent atrial fibrillation.N Engl J Med · 20151,946 citationsRCR 83.0
- Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.N Engl J Med · 2021690 citationsRCR 52.5
- Placebo-controlled trial of amantadine for severe traumatic brain injury.N Engl J Med · 2012586 citationsRCR 22.4
- Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.Circulation · 2019497 citationsRCR 28.3
- Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.N Engl J Med · 2023332 citationsRCR 44.0
- Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial.Eur Heart J · 2010226 citationsRCR 6.6
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial.Lancet Neurol · 2017215 citationsRCR 8.4
- 185 citationsRCR 7.5
- Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes.Diabetes Care · 2014169 citationsRCR 6.0
- Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes.Diabetes · 2015148 citationsRCR 5.5